Yoshinari Myoken

Title: Innovations of Yoshinari Myoken

Introduction

Yoshinari Myoken is a notable inventor based in Lake Placid, NY (US). He has made significant contributions to the field of cell science, particularly in the isolation of hybridomas. His innovative methods have the potential to enhance research in various biological applications.

Latest Patents

Yoshinari Myoken holds a patent for a method that utilizes cholesterol auxotrophy of myeloma cells as a basis for selecting hybridomas. This method demonstrates that the outgrowth of nascent hybridomas in a cholesterol-free medium is 3- to 9-fold more efficient than that in HAT medium. It results in 3- to 13-times as many antigen-reactive hybridoma cells. This selection method can be applied with any sterol-dependent parent cell line, and the nutrient medium is preferably free of Ham's F-12 nutrient mixture. He has 1 patent to his name.

Career Highlights

Yoshinari Myoken is associated with the W. Alton Jones Cell Science Center Incorporated, where he has been able to apply his innovative techniques in a professional setting. His work has contributed to advancements in hybridoma technology, which is crucial for antibody production and other biotechnological applications.

Collaborations

Throughout his career, Yoshinari has collaborated with notable colleagues, including Tetsuji Okamoto and J Denry Sato. These collaborations have likely enriched his research and contributed to the success of his innovative methods.

Conclusion

Yoshinari Myoken's contributions to the field of cell science through his innovative patent demonstrate his commitment to advancing research methodologies. His work continues to influence the development of hybridoma technology and its applications in various scientific fields.